Johnston S Claiborne, Mendis Shanthi, Mathers Colin D
Department of Neurology, Box 0114, University of California, San Francisco, 505 Parnassus Avenue, M-798, San Francisco, CA 94143-0114, USA.
Lancet Neurol. 2009 Apr;8(4):345-54. doi: 10.1016/S1474-4422(09)70023-7. Epub 2009 Feb 21.
Recent improvements in the monitoring and modelling of stroke have led to more reliable estimates of stroke mortality and burden worldwide. However, little is known about the global distribution of stroke and its relations to the prevalence of cardiovascular disease risk factors and sociodemographic and economic characteristics.
National estimates of stroke mortality and burden (measured in disability-adjusted life years [DALYs]) were calculated from monitoring vital statistics, a systematic review of studies that report disease surveillance, and modelling as part of the WHO Global Burden of Disease programme. Similar methods were used to generate standardised measures of the national prevalence of cardiovascular risk factors. Risk factors other than diabetes and disease burden estimates were age-adjusted and sex-adjusted to the WHO standard population.
There was a ten-fold difference in rates of stroke mortality and DALY loss between the most-affected and the least-affected countries. Rates of stroke mortality and DALY loss were highest in eastern Europe, north Asia, central Africa, and the south Pacific. National per capita income was the strongest predictor of mortality and DALY loss rates (p<0.0001) even after adjustment for cardiovascular risk factors (p<0.0001). Prevalences of cardiovascular risk factors measured at a national level were generally poor predictors of national stroke mortality rates and burden, although raised mean systolic blood pressure (p=0.028) and low body-mass index (p=0.017) predicted stroke mortality, and greater prevalence of smoking predicted both stroke mortality (p=0.041) and DALY-loss rates (p=0.034).
Rates of stroke mortality and burden vary greatly among countries, but low-income countries are the most affected. Current measures of the prevalence of cardiovascular risk factors at the population level poorly predict overall stroke mortality and burden and do not explain the greater burden in low-income countries.
近期中风监测和建模方面的进展使得全球范围内中风死亡率和负担的估计更加可靠。然而,对于中风的全球分布及其与心血管疾病风险因素的患病率以及社会人口和经济特征之间的关系,我们知之甚少。
中风死亡率和负担(以伤残调整生命年 [DALYs] 衡量)的国家估计值是通过监测生命统计数据、对报告疾病监测的研究进行系统综述以及作为世界卫生组织全球疾病负担计划一部分的建模计算得出的。采用类似方法生成心血管风险因素国家患病率的标准化测量值。除糖尿病外的风险因素和疾病负担估计值按年龄和性别调整至世界卫生组织标准人群。
受影响最严重和最轻微的国家之间,中风死亡率和 DALY 损失率相差十倍。中风死亡率和 DALY 损失率在东欧、北亚、中非和南太平洋地区最高。即使在调整心血管风险因素后(p<0.0001),国家人均收入仍是死亡率和 DALY 损失率的最强预测因素(p<0.0001)。尽管平均收缩压升高(p = 0.028)和低体重指数(p = 0.017)可预测中风死亡率,吸烟率更高可预测中风死亡率(p = 0.041)和 DALY 损失率(p = 0.034),但在国家层面测量的心血管风险因素患病率通常不是国家中风死亡率和负担的良好预测指标。
各国中风死亡率和负担差异很大,但低收入国家受影响最大。目前在人群层面测量的心血管风险因素患病率难以预测总体中风死亡率和负担,也无法解释低收入国家负担较重的原因。